Search

Your search keyword '"Csajka, Chantal"' showing total 389 results

Search Constraints

Start Over You searched for: Author "Csajka, Chantal" Remove constraint Author: "Csajka, Chantal" Language english Remove constraint Language: english
389 results on '"Csajka, Chantal"'

Search Results

9. Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study.

10. A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial.

16. Drug-drug interactions with oral anticoagulants: information consistency assessment of three commonly used online drug interactions databases in Switzerland.

17. Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometry

22. Apixaban and rivaroxaban's physiologically‐based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side.

24. Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project [case report]

27. Population pharmacokinetics of apixaban in a real‐life hospitalized population from the OptimAT study.

28. Modeling tumor size dynamics based on real‐world electronic health records and image data in advanced melanoma patients receiving immunotherapy.

34. Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services

35. Semiautomated Pipeline to Quantify Tumor Evolution From Real-World Positron Emission Tomography/Computed Tomography Imaging.

38. From Personalized to Precision Medicine in Oncology: A Model-Based Dosing Approach to Optimize Achievement of Imatinib Target Exposure.

40. Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIV

41. Multidomain interventions:state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6

42. Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6

43. Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals

46. Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study.

47. Population pharmacokinetic analyses of regorafenib and capecitabine in patients with locally advanced rectal cancer (SAKK 41/16 RECAP).

48. Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations.

49. Evaluation of the association of anticholinergic burden and delirium in older hospitalised patients – A cohort study comparing 19 anticholinergic burden scales.

50. Automatic Detection of Adverse Drug Events in Geriatric Care: Study Proposal.

Catalog

Books, media, physical & digital resources